This announcement is a separate document:
立信会计师事务所关于国邦医药2023年内部控制审计报告
Lixin Certified Public Accountants on Guobang Pharmaceutical\'s 2023 Internal Control Audit Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.